Streetbeat News

Analyst Ratings

HRMY

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Harmony Biosciences (NASDAQ:HRMY) and maintained a price target of $66.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 10:07 am

SNPS

Needham analyst Charles Shi has reiterated a 'Buy' rating on Synopsys (NASDAQ:SNPS) and maintained a price target of $500.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 10:06 am

HUYA

HUYA reported Q2 adjusted earnings per ADS of $0.06, beating the analyst consensus estimate of $0.01 by 500%. However, the company's quarterly sales of $251.20 million missed the analyst consensus estimate of $288.24 million by 12.85%. This represents a 26.05% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:02 am

XXII

TD Cowen analyst Vivien Azer has downgraded 22nd Century Group (NASDAQ:XXII) from Outperform to Market Perform and lowered the price target from $5 to $2.5.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:43 am

RDFN

Oppenheimer analyst Jason Helfstein has upgraded Redfin (NASDAQ:RDFN) from Underperform to Perform.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:42 am

TSBX

Piper Sandler analyst Joseph Catanzaro has initiated coverage on Turnstone Biologics (NASDAQ:TSBX) with an Overweight rating and a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:40 am

NFGC

Roth MKM analyst Mike Niehuser has initiated coverage on New Found Gold (AMEX:NFGC) with a Buy rating and a price target of $9.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:39 am

ODD

Barclays analyst Lauren Lieberman has initiated coverage on ODDITY Tech (NASDAQ:ODD) with an Overweight rating and a price target of $57.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:37 am

FRO

JP Morgan analyst Samuel Bland has initiated coverage on Frontline (NYSE:FRO) with a Neutral rating and a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:26 am

AGTI

Citigroup analyst Jason Cassorla has downgraded Agiliti (NYSE:AGTI) from Buy to Neutral and lowered the price target from $20 to $13.

Portfolio Pulse from richadhand@benzinga.com

August 15, 2023 | 9:23 am